Newcastle Primary Care Trust

Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway

Collaborator, Phase 4, Not yet recruiting, 2027, 7,000 people, 2 Oct 2026, clinicaltrials.gov

NCT06145360

Phase 4, Completed, 2023, 150 people, 24 Nov 2023, clinicaltrials.gov

NCT06140108

Phase 2/3, Completed, 2023, 70 people, 18 Nov 2023, clinicaltrials.gov

NCT05539625

Collaborator, Phase 2, Withdrawn, 2025, 0 people, 14 Sept 2022, clinicaltrials.gov

NCT04888741

Collaborator, Phase 2, Recruiting, 2021, 400 people, 17 May 2021, clinicaltrials.gov

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Collaborator, Phase 3, Completed, 2020, 410 people, 26 Jun 2018, clinicaltrials.gov

NCT00360984

Collaborator, Phase 4, Completed, 2003, 21 people, 7 Aug 2006, clinicaltrials.gov